Cargando…

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine

Detalles Bibliográficos
Autores principales:	Wu, Kai, Werner, Anne P., Koch, Matthew, Choi, Angela, Narayanan, Elisabeth, Stewart-Jones, Guillaume B.E., Colpitts, Tonya, Bennett, Hamilton, Boyoglu-Barnum, Seyhan, Shi, Wei, Moliva, Juan I., Sullivan, Nancy J., Graham, Barney S., Carfi, Andrea, Corbett, Kizzmekia S., Seder, Robert A., Edwards, Darin K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008744/ https://www.ncbi.nlm.nih.gov/pubmed/33730471 http://dx.doi.org/10.1056/NEJMc2102179

Ejemplares similares

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants
por: Choi, Angela, et al.
Publicado: (2021)

COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge
por: DiPiazza, Anthony T., et al.
Publicado: (2021)

Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
por: Wu, Kai, et al.
Publicado: (2021)

mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron
por: Lee, Hye Kyung, et al.
Publicado: (2022)

mRNA-1273 Protects against SARS-CoV-2 Beta Infection in Nonhuman Primates
por: Corbett, Kizzmekia S., et al.
Publicado: (2021)

Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive protection across divergent subgroups
por: Hutchinson, Geoffrey, et al.
Publicado: (2022)

Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses
por: Boyoglu-Barnum, Seyhan, et al.
Publicado: (2020)

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
por: Gagne, Matthew, et al.
Publicado: (2022)

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development
por: Boyoglu-Barnum, Seyhan, et al.
Publicado: (2019)

Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung
por: Gagne, Matthew, et al.
Publicado: (2022)

Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera
por: Hutchinson, Geoffrey B., et al.
Publicado: (2023)

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
por: Corbett, Kizzmekia S., et al.
Publicado: (2020)

A Platform Incorporating Trimeric Antigens into Self-Assembling Nanoparticles Reveals SARS-CoV-2-Spike Nanoparticles to Elicit Substantially Higher Neutralizing Responses than Spike Alone
por: Zhang, Baoshan, et al.
Publicado: (2020)

A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone
por: Zhang, Baoshan, et al.
Publicado: (2020)

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages
por: Corbett, Kizzmekia S., et al.
Publicado: (2019)

mRNA-1273 Vaccine-elicited Neutralization of SARS-CoV-2 Omicron in Adolescents and Children
por: Girard, Bethany, et al.
Publicado: (2022)

mRNA-1273 vaccination protects against SARS-CoV-2–elicited lung inflammation in nonhuman primates
por: Waickman, Adam T., et al.
Publicado: (2022)

Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice
por: Garcia-Dominguez, Dario, et al.
Publicado: (2022)

Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes
por: McCraw, Dustin M., et al.
Publicado: (2023)

SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques
por: Garrido, Carolina, et al.
Publicado: (2021)

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants
por: Pegu, Amarendra, et al.
Publicado: (2021)

Primary Human mDC1, mDC2, and pDC Dendritic Cells Are Differentially Infected and Activated by Respiratory Syncytial Virus
por: Johnson, Teresa R., et al.
Publicado: (2011)

The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD
por: Greaney, Allison J., et al.
Publicado: (2021)

Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles
por: Zhang, Peng, et al.
Publicado: (2023)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses
por: Yang, Yongping, et al.
Publicado: (2021)

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
por: Anderson, Evan J., et al.
Publicado: (2020)

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
por: Choi, Angela, et al.
Publicado: (2021)

Career advice from my father: “Go where you are loved”
por: Corbett, Kizzmekia S.
Publicado: (2021)

Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial
por: Chu, Laurence, et al.
Publicado: (2022)

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
por: Kanekiyo, Masaru, et al.
Publicado: (2019)

Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization
por: Doria-Rose, Nicole A., et al.
Publicado: (2021)

Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43
por: Boonyaratanakornkit, Jim, et al.
Publicado: (2021)

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates
por: Francica, Joseph R., et al.
Publicado: (2021)

Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects
por: Edwards, Darin K, et al.
Publicado: (2022)

Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
por: Shi, Wei, et al.
Publicado: (2022)

Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
por: Shi, Wei, et al.
Publicado: (2022)

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
por: Wrapp, Daniel, et al.
Publicado: (2020)

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
por: Wrapp, Daniel, et al.
Publicado: (2020)

Comparison of BNT162b2-, mRNA-1273- and Ad26.COV2.S-Elicited IgG and Neutralizing Titers against SARS-CoV-2 and Its Variants
por: Padhiar, Nigam H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dteqlkcgs2b70iss7ikbbm5e2b